Alzheimer’s disease facts and figures. Alzheimers Dement. 2023;19(4):1598–695.
Collaborators, G.B.D.D.F. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105–25.
Hansson O, et al. The Alzheimer’s Association appropriate use recommendations for blood biomarkers in Alzheimer’s disease. Alzheimers Dement. 2022;18(12):2669–86.
Article PubMed CAS Google Scholar
Teunissen CE, et al. Blood-based biomarkers for Alzheimer’s disease: towards clinical implementation. Lancet Neurol. 2022;21(1):66–77.
Article PubMed CAS Google Scholar
Lee CS, et al. Associations between recent and established ophthalmic conditions and risk of Alzheimer’s disease. Alzheimers Dement. 2019;15(1):34–41.
Hwang PH, et al. Ophthalmic conditions associated with dementia risk: The Cardiovascular Health Study. Alzheimers Dement. 2021;17(9):1442–51.
Gregory RL. Origin of eyes and brains. Nature. 1967;213(5074):369–72.
Article PubMed CAS Google Scholar
Subramanian ML, et al. Neurofilament light chain in the vitreous humor of the eye. Alzheimers Res Ther. 2020;12(1):111.
Article PubMed PubMed Central CAS Google Scholar
Sheikh Z, et al. The association of vitreous biomarker levels and optical coherence tomography markers to cognitive status. Invest Ophthalmol Vis Sci. 2023;64(8):5276.
Vig V, et al. Vitreous humor biomarkers reflect pathological changes in the brain for Alzheimer’s disease and chronic traumatic encephalopathy. J Alzheimers Dis. 2023;93(3):1181–93.
Article PubMed PubMed Central CAS Google Scholar
Bai J, et al. Association of cognitive function with neurofilament light chain in the aqueous humor of human eye. Front Aging Neurosci. 2022;14:1027705.
Article PubMed PubMed Central CAS Google Scholar
Kwak DE, et al. Alterations of aqueous humor Abeta levels in Abeta-infused and transgenic mouse models of Alzheimer disease. PLoS ONE. 2020;15(1):e0227618.
Article PubMed PubMed Central CAS Google Scholar
Janciauskiene S, et al. Detection of Alzheimer peptides and chemokines in the aqueous humor. Eur J Ophthalmol. 2011;21(1):104–11.
Inoue T, Kawaji T, Tanihara H. Elevated levels of multiple biomarkers of Alzheimer’s disease in the aqueous humor of eyes with open-angle glaucoma. Invest Ophthalmol Vis Sci. 2013;54(8):5353–8.
Article PubMed CAS Google Scholar
Kallo G, et al. Changes in the chemical barrier composition of tears in Alzheimer’s disease reveal potential tear diagnostic biomarkers. PLoS ONE. 2016;11(6):e0158000.
Article PubMed PubMed Central Google Scholar
Kenny A, et al. Proteins and microRNAs are differentially expressed in tear fluid from patients with Alzheimer’s disease. Sci Rep. 2019;9(1):15437.
Article PubMed PubMed Central Google Scholar
Del Prete S, Marasco D, Sabetta R, Del Prete A, Marino FZ, Franco R, Troisi S, Troisi M, Cennamo G. Tear Liquid for Predictive Diagnosis of Alzheimer’s Disease. Reports. 2021;4(3):26. https://doi.org/10.3390/reports4030026.
Gijs M, et al. Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration. Sci Rep. 2021;11(1):22675.
Article PubMed PubMed Central CAS Google Scholar
Karampatakis V, et al. Comparison between normal values of 2- and 5-minute Schirmer test without anesthesia. Cornea. 2010;29(5):497–501.
Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155–63.
Article PubMed PubMed Central Google Scholar
Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8(2):135–60.
Article PubMed CAS Google Scholar
Oktem EO, et al. The relationship between the degree of cognitive impairment and retinal nerve fiber layer thickness. Neurol Sci. 2015;36(7):1141–6.
Cunha LP, et al. Macular thickness measurements with frequency domain-OCT for quantification of retinal neural loss and its correlation with cognitive impairment in Alzheimer’s disease. PLoS ONE. 2016;11(4):e0153830.
Article PubMed PubMed Central Google Scholar
Garcia-Martin ES, et al. Macular thickness as a potential biomarker of mild Alzheimer’s disease. Ophthalmology. 2014;121(5):1149-1151 e3.
den Haan J, et al. Retinal thickness correlates with parietal cortical atrophy in early-onset Alzheimer’s disease and controls. Alzheimers Dement (Amst). 2018;10:49–55.
Garcia-Martin E, et al. Ganglion cell layer measurements correlate with disease severity in patients with Alzheimer’s disease. Acta Ophthalmol. 2016;94(6):e454–9.
Cunha JP, et al. OCT in Alzheimer’s disease: thinning of the RNFL and superior hemiretina. Graefes Arch Clin Exp Ophthalmol. 2017;255(9):1827–35.
Liu S, et al. The association between retinal neuronal layer and brain structure is disrupted in patients with cognitive impairment and Alzheimer’s disease. J Alzheimers Dis. 2016;54(2):585–95.
Trebbastoni A, et al. Attenuation of choroidal thickness in patients with Alzheimer disease: evidence from an Italian prospective study. Alzheimer Dis Assoc Disord. 2017;31(2):128–34.
Bayhan HA, et al. Evaluation of the chorioretinal thickness changes in Alzheimer’s disease using spectral-domain optical coherence tomography. Clin Exp Ophthalmol. 2015;43(2):145–51.
Gharbiya M, et al. Choroidal thinning as a new finding in Alzheimer’s disease: evidence from enhanced depth imaging spectral domain optical coherence tomography. J Alzheimers Dis. 2014;40(4):907–17.
Cheung CY, et al. Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis. 2015;45(1):45–56.
Article PubMed CAS Google Scholar
O’Bryhim BE, et al. Association of preclinical Alzheimer disease with optical coherence tomographic angiography findings. JAMA Ophthalmol. 2018;136(11):1242–8.
Article PubMed PubMed Central Google Scholar
Querques G, et al. Functional and morphological changes of the retinal vessels in Alzheimer’s disease and mild cognitive impairment. Sci Rep. 2019;9(1):63.
留言 (0)